R W Brockman. Show Affiliations »
Abstract
Mesh： See more » Alkylating Agents/therapeutic useAnimalsAntineoplastic Agents/metabolismAntineoplastic Agents/pharmacologyAntineoplastic Agents/therapeutic useBleomycin/therapeutic useCamptothecin/therapeutic useCell Division/drug effectsCytarabine/therapeutic useDNA, Neoplasm/biosynthesisDeferoxamine/therapeutic useDiamines/therapeutic useDoxorubicin/therapeutic useDrug Therapy, CombinationLeukemia L1210/drug therapyLeukemia L1210/mortalityMacromolecular SubstancesMiceNeoplasms/drug therapyNeoplasms, Experimental/drug therapyNitrosourea Compounds/therapeutic usePurine Nucleotides/biosynthesisRibonucleotide Reductases/analysisThioguanine/metabolismThioguanine/therapeutic useThioguanine/toxicityTriazoles/therapeutic use
Substances： See more » Alkylating AgentsAntineoplastic AgentsDNA, NeoplasmDiaminesMacromolecular SubstancesNitrosourea CompoundsPurine NucleotidesTriazolesCytarabineBleomycinDoxorubicinRibonucleotide ReductasesThioguanineDeferoxamineCamptothecin
Year: 1974 PMID： 4135108
Source DB: PubMed Journal: Cancer Chemother Rep 2 ISSN： 0069-0120